Form 4 for PAHC PHIBRO ANIMAL HEALTH CORP
Accepted 2025-02-11 00:00:00 ET · period of report 2025-02-09 · accession 0001104659-25-011486 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-02-11 | 2025-02-09 | PAHC | David Glenn | CFO | M - OptEx | — | +30.0K | 30.0K | New | — |
| D | 2025-02-11 | 2025-02-09 | PAHC | David Glenn | CFO | M - OptEx | $0.00 | -30.0K | 270.0K | -10% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-02-09 | M | A | 30,000 | — | 30,000 | D | — | — | (F1) Shares were issued in settlement of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Class A Common Stock. No shares of Class A Common Stock were transferred or sold upon the vesting of the RSUs listed in Table II and the reporting person will pay the related tax withholding obligations in cash. |
| 2 | Derivative | Restricted Stock Units | 2025-02-09 | M | D | 30,000 | $0.00 | 270,000 | D | — · — to — | 30,000 Class A Common Stock | (F1) Shares were issued in settlement of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Class A Common Stock. No shares of Class A Common Stock were transferred or sold upon the vesting of the RSUs listed in Table II and the reporting person will pay the related tax withholding obligations in cash. (F3) Pursuant to the Award Agreement, (i) 150,000 RSUs are subject to time vesting (collectively, the "Time Vesting RSUs") and vest in equal installments on each of the first five anniversaries of the Grant Date, subject to continued service through each such vesting date, and (ii) 150,000 RSUs are subject to performance vesting (collectively, the "Performance Vesting RSUs") and vest (with linear interpolation to apply for achievement between increments) based upon achievement of the arithmetic average of Phibro Animal Health Corporation's closing stock price per share for each trading day in the 90-calendar day period ending five years from the Grant Date, from $20 to $60 and above, subject to Mr. David's continued employment on such date. Time Vesting RSUs and Performance Vesting RSUs, in each case, are subject to earlier vesting upon certain qualifying termination events. (F2) On February 9, 2024 (the "Grant Date"), the reporting person was granted 300,000 RSUs pursuant to the Issuer's 2008 Incentive Plan and an RSU award agreement (the "Award Agreement"). |